货号:A769555
同义名:
RORgamma-t-IN-1
GSK805 是一种口服活性 RORγt 抑制剂,能够穿透中枢神经系统。GSK805 抑制 RORγ 和 Th17 细胞分化,其 pIC50 分别为 8.4 和 >8.2。GSK805抑制 Th17 细胞功能,可用于免疫学研究。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | RORγt-IN-1 is a potent, orally bioavailable RORγt inhibitor with pIC50 of 8.4 and > 8.2 for RORγ FRET assay and Th17 assay. |
| Concentration | Treated Time | Description | References | |
| HCC70 cells | 5 μM | 48 hours | To evaluate the effect of GSK805 on cholesterol biosynthesis gene expression, results showed that GSK805 significantly down-regulated the expression of cholesterol biosynthesis genes. | Pharmacol Res. 2022 Aug;182:106324 |
| MDA-MB468 cells | 2.5 μM | 24 hours | To evaluate the effect of GSK805 on cholesterol biosynthesis gene expression, results showed that GSK805 significantly down-regulated the expression of cholesterol biosynthesis genes. | Pharmacol Res. 2022 Aug;182:106324 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Necrotizing enterocolitis (NEC) model | Oral | 10 μg/g | Once daily for four days | GSK805 ameliorates NEC severity by inhibiting Th17 responses | Cell Biosci. 2022 Jan 4;12(1):3 |
| Mice | Mild subarachnoid hemorrhage model | Oral gavage | 30mg/kg | Once daily for 14 days | Inhibition of ROR γt decreased IL-17 production, thereby suppressing neutrophil entry into the CNS after subarachnoid hemorrhage | Neurocrit Care. 2020 Aug;33(1):140-151 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.88mL 0.38mL 0.19mL |
9.39mL 1.88mL 0.94mL |
18.78mL 3.76mL 1.88mL |
|
| CAS号 | 1426802-50-7 |
| 分子式 | C23H18Cl2F3NO4S |
| 分子量 | 532.36 |
| SMILES Code | O=C(NC1=CC(Cl)=C(C2=CC=CC=C2OC(F)(F)F)C(Cl)=C1)CC3=CC=C(S(=O)(CC)=O)C=C3 |
| MDL No. | MFCD28902182 |
| 别名 | RORgamma-t-IN-1 |
| 运输 | 蓝冰 |
| InChI Key | CEICQMBWAQAIQX-UHFFFAOYSA-N |
| Pubchem ID | 71285927 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(197.24 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1